Preparing GHRP-6 for In Vitro Research: Step-by-Step Reconstitution Guide
The content, articles and product information provided on this website are strictly educational and informational. They are intended to be used for in vitro research only. “In vitro” is a Latin phrase, “in glass,” that refers to research that is conducted outside of a living organism. Note, these products are not pharmaceuticals or medicines and have not been approved by the FDA for the diagnosis, treatment or prevention of any illnesses or disorders. These products are legally prohibited from human or animal consumption.
Preparing GHRP-6 for In Vitro Research: Step-by-Step Reconstitution Guide
GHRP-6 (Growth Hormone Releasing Peptide-6, His-D-Trp-Ala-Trp-D-Phe-Lys-NH2, MW 873.05 g/mol, CAS 87616-84-0) is a synthetic hexapeptide GHSR-1a agonist and one of the first-generation growth hormone releasing peptides used extensively in in vitro receptor pharmacology research. It is supplied as a lyophilised white powder in a 10mL sterile glass vial containing 5mg of peptide. GHRP-6 is readily soluble in aqueous media and straightforward to reconstitute for GHSR-1a research applications.
Materials Required
- GHRP-6 5mg lyophilised vial
- Bacteriostatic water (BAC water) — 10mL vial
- 1mL sterile syringe with needle
- Alcohol swabs (70% isopropyl)
- Nitrile gloves
- Permanent marker for labelling
- Refrigerator at 2–8°C for storage
Pre-Reconstitution Preparation
Inspect the GHRP-6 vial to confirm an intact lyophilised powder and unbroken seal. Remove from cold storage and equilibrate to room temperature for 10 minutes. GHRP-6's hexapeptide structure and histidine-containing N-terminus make it highly soluble in aqueous media — dissolution is essentially immediate upon contact with BAC water.
Step-by-Step Reconstitution Protocol
Step 1 — Prepare workspace. Wipe the work surface with 70% isopropyl alcohol and allow to dry. Wear nitrile gloves.
Step 2 — Swab both stoppers. Clean rubber stoppers on both vials with separate fresh alcohol swabs. Air dry 10 seconds each.
Step 3 — Draw 2mL of BAC water. Draw 2mL of bacteriostatic water into a sterile syringe.
Step 4 — Inject along the vial wall. Direct the BAC water slowly down the inner glass wall of the GHRP-6 vial over 10–15 seconds. Avoid direct stream onto the powder.
Step 5 — Dissolve gently. Swirl gently for 15–20 seconds. GHRP-6 dissolves rapidly — the solution becomes clear and colourless almost immediately. Do not shake.
Step 6 — Inspect and label. Confirm clarity. Label with reconstitution date, concentration, and initials.
Resulting Concentration
Adding 2mL BAC water to a 5mg GHRP-6 vial yields a stock concentration of 2.5mg/mL (2500mcg/mL). For GHSR-1a binding assays, Gq/calcium flux studies, and GH secretion assays in GH3 pituitary cell model preparations, working concentrations of 0.1nM–1µM are prepared by serial dilution.
Concentration Reference Table
| BAC Water Volume Added | Resulting Concentration |
|---|---|
| 1mL | 5.0mg/mL (5000mcg/mL) |
| 2mL | 2.5mg/mL (2500mcg/mL) |
| 5mL | 1.0mg/mL (1000mcg/mL) |
Storage Conditions and Stability
Store lyophilised GHRP-6 at −20°C prior to reconstitution. Once reconstituted, store at 2–8°C. Reconstituted GHRP-6 in BAC water is stable for up to 28 days under refrigeration. Do not freeze reconstituted solution. GHRP-6 is stable across physiological pH ranges and compatible with standard cell culture media. Prepare single-use aliquots for long-term −80°C storage to avoid freeze-thaw cycles.
Troubleshooting Common Reconstitution Issues
Powder not dissolving: Although rare for small hexapeptides, if any powder adheres to the glass wall, gently tilt the vial and swirl to bring it into contact with the solvent. Do not heat the vial. If dissolution remains incomplete after 60 seconds of gentle swirling, the vial may have been compromised by moisture ingress — inspect for any signs of a previously broken seal.
Cloudy solution: A properly reconstituted solution should be clear and colourless. Cloudiness can indicate microbial contamination (do not use), peptide aggregation from incorrect pH or temperature, or introduction of particulate matter. Discard the vial if cloudiness persists after gentle swirling.
Foaming: If foam forms during injection, this typically indicates the solvent was injected too quickly or directly onto the powder. Allow foam to settle naturally — do not shake. Once settled, gently swirl until fully dissolved. Foaming is rarely an issue with small hexapeptides but can occur if injection speed is too fast.
Loss of compound on vial walls: Ensure all reconstituted solution is recovered by gently swirling the vial so the solution contacts all inner wall surfaces. For maximum recovery, invert the vial and draw from the stopper end using a syringe after dissolution is complete.
Research Application Notes
GHRP-6 was among the first synthetic GHSR-1a agonists characterised, making it a historically important reference compound in GH axis receptor pharmacology. Compared to the second-generation GHRP-2 and third-generation ipamorelin, GHRP-6 has lower GHSR-1a binding affinity but equivalent maximal efficacy for Gq-coupled calcium mobilisation in pituitary somatotroph cell models. This pharmacological profile makes GHRP-6 useful for right-shift comparative studies confirming GHSR-1a-mediated responses via Schild regression analysis alongside more potent reference agonists. GHRP-6 also stimulates ghrelin-receptor-independent appetite-signalling pathways in hypothalamic cell models — include appropriate receptor controls when interpreting multi-pathway signalling results. GHRP-6 5mg vials are available from Pinnacle Peptides, verified at ≥99% purity by HPLC and mass spectrometry.
All content is intended for in vitro laboratory research purposes only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any condition.
